These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3287546)

  • 1. [Clinical profile of a new antihypertensive agents. Ketanserin].
    Symoens J
    Rev Med Liege; 1988 Mar; 43 Suppl 1():38-49. PubMed ID: 3287546
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with ketanserin and ritanserin in hypertensive patients.
    Hedner T; Persson B
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S44-8. PubMed ID: 2459514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What does the introduction of ketanserin for the treatment of arterial hypertension represent?].
    Rorive G; Carlier PG; Krzesinski JM
    Rev Med Liege; 1988 Mar; 43 Suppl 1():50-4. PubMed ID: 3375650
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical investigation of the effect of ketanserin: a new antihypertensive drug.
    Coto V; Oliviero U; Cocozza M; Lucariello A; Picano T; Coto F; Cacciatore L
    Drugs Exp Clin Res; 1989; 15(5):231-4. PubMed ID: 2676440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rationale for ketanserin therapy in hypertension.
    Hansson L; Hedner T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S39-44. PubMed ID: 2446068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study.
    Beretta-Piccoli C; Amstein R; Bertel O; Brunner HR; Bühler FR; Follath F; Solèr M; Vallotton M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S119-23. PubMed ID: 2446058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat.
    Persson B; Gradin K; Pettersson A; Hedner T
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy.
    Bolte AC; van Eyck J; Strack van Schijndel RJ; van Geijn HP; Dekker GA
    Br J Obstet Gynaecol; 1998 Jul; 105(7):723-31. PubMed ID: 9692412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of pharmacologic blockade of serotonin receptors (S2) on arterial pressure in rats with 2 forms of hereditary arterial hypertension].
    Popova NK; Piianzin AI; Markel' AL
    Farmakol Toksikol; 1989; 52(6):58-61. PubMed ID: 2516487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and compliance of great arteries in man: a double-blind crossover study].
    Crispino M
    Ann Ital Med Int; 1990; 5(4 Pt 2):469-76. PubMed ID: 2102134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure patterns in pregnant patients on oral ketanserin.
    Steyn DW; Odendaal HJ
    Cardiovasc J S Afr; 2001; 12(2):82-7. PubMed ID: 11447496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
    J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension.
    De Crée J; Leempoels J; Geukens H; De Cock W; Verhaegen H
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():473s-476s. PubMed ID: 7032829
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of ketanserin and metoprolol in essential hypertension.
    Seedat YK; Parag KB
    S Afr Med J; 1985 Oct; 68(8):555-8. PubMed ID: 2931840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of action and use of antagonists of serotonin receptors S2, especially ketanserin, in the treatment of various diseases of the cardiovascular system].
    Wiecek A; Grzeszczak W
    Pol Tyg Lek; 1987 Mar; 42(10):304-8. PubMed ID: 3299308
    [No Abstract]   [Full Text] [Related]  

  • 19. Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuria.
    Casagrande P; Valvo E; Bedogna V; Loschiavo C; Giorgetti P; Graziani MS; Maschio G
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):79-83. PubMed ID: 2307549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of the anti-hypertensive agent ketanserin in hypertension in man.
    Weiss YA; Fournier V; Pannier B; Laurent S; Safar ME
    Acta Cardiol; 1987; 42(5):329-37. PubMed ID: 3321806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.